Tapering Considerations: Gradually reduce GLP-1 dosing while increasing fiber and protein intake Begin nutraceutical support (e.g., berberine, chromium) 24 weeks prior to taper Monitor lean mass and glycemic variability Support appetite signaling with mindful eating and circadian regulation Address gut motility and emotional eating patterns with botanical support Clinical Example: A Case in Practice A 52-year-old female on semaglutide for 6 months presented with nausea, fatigue, and concern about lean mass loss
Home pregnancy test kit is 99% accurate, but due to other medical conditions, faulty or expired test kit, user error, incorrect test usage, previous abortions and miscarriages, and some medications may lead to a false-positive pregnancy test result
Acknowledgements This study was supported by NSFC 82401072
It does not predict your response to tirzepatide or determine your dose
The superior weight loss achieved with semaglutide may reduce the need for additional weight loss interventions, obesity-related medical treatments, or bariatric surgery
Filed Lawsuit: CECILY KING V